Brown Advisory Inc Biogen Inc. Transaction History

Brown Advisory Inc

$77.3 Billion
Q3 2024

A detailed history of Brown Advisory Inc transactions in Biogen Inc. stock. As of the latest transaction made, Brown Advisory Inc holds 333,227 shares of BIIB stock, worth $48.8 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

333,227

Previous 347,518 4.11%

Holding current value

$48.8 Million

Previous $80.6 Million 19.82%

% of portfolio

0.08%

Previous 0.11%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$189.07 - $236.8 $2.7 Million - $3.38 Million	-14,291 Reduced 4.11%	333,227 $64.6 Million
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $14.2 Million - $17.7 Million	74,638 Added 27.35%	347,518 $80.6 Million
Q1 2024 Apr 24, 2024	BUY	$212.02 - $267.71 $21.5 Million - $27.2 Million	101,576 Added 59.3%	272,880 $58.8 Million
Q4 2023 Feb 08, 2024	BUY	$222.59 - $267.94 $507,950 - $611,439	2,282 Added 1.35%	171,304 $44.3 Million
Q3 2023 Oct 24, 2023	BUY	$253.3 - $285.89 $1.07 Million - $1.21 Million	4,219 Added 2.56%	169,022 $43.4 Million
Q2 2023 Jul 31, 2023	BUY	$275.25 - $318.06 $988,147 - $1.14 Million	3,590 Added 2.23%	164,803 $46.9 Million
Q1 2023 May 08, 2023	BUY	$256.56 - $292.34 $2.97 Million - $3.39 Million	11,582 Added 7.74%	161,213 $44.8 Million
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $6.12 Million - $7.43 Million	24,231 Added 19.32%	149,631 $41.4 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $1.76 Million - $2.42 Million	9,025 Added 7.76%	125,400 $33.5 Million
Q2 2022 Nov 14, 2022	BUY	$187.54 - $223.02 $1.36 Million - $1.61 Million	7,240 Added 6.63%	116,375 $23.7 Million
Q2 2022 Sep 13, 2022	BUY	$187.54 - $223.02 $5.44 Million - $6.47 Million	29,014 Added 14.56%	228,273 $46.6 Million
Q2 2022 Aug 02, 2022	SELL	$187.54 - $223.02 $2.72 Million - $3.23 Million	-14,484 Reduced 6.78%	199,259 $47.7 Million
Q1 2022 Nov 14, 2022	SELL	$193.77 - $244.14 $23.1 Million - $29.1 Million	-119,138 Reduced 52.19%	109,135 $23 Million
Q1 2022 Sep 13, 2022	BUY	$193.77 - $244.14 $2.8 Million - $3.52 Million	14,434 Added 7.24%	213,743 $45 Million
Q1 2022 May 09, 2022	SELL	$193.77 - $244.14 $3,294 - $4,150	-17 Reduced 0.01%	199,309 $47.7 Million
Q4 2021 Jan 27, 2022	BUY	$223.92 - $287.77 $32.2 Million - $41.4 Million	143,819 Added 259.1%	199,326 $47.8 Million
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $12.2 Million - $15.9 Million	43,163 Added 349.67%	55,507 $15.7 Million
Q2 2021 Jul 29, 2021	BUY	$259.0 - $414.71 $1.02 Million - $1.64 Million	3,953 Added 47.11%	12,344 $4.28 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $956,251 - $1.12 Million	3,936 Added 88.35%	8,391 $2.35 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $22,444 - $33,784	-95 Reduced 2.09%	4,455 $1.09 Million
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $32,831 - $37,908	124 Added 2.8%	4,550 $1.29 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $261,246 - $345,975	-1,010 Reduced 18.58%	4,426 $1.18 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $226,371 - $287,155	-842 Reduced 13.41%	5,436 $1.72 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $38,290 - $52,908	-174 Reduced 2.7%	6,278 $1.86 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $37,617 - $42,191	-173 Reduced 2.61%	6,452 $1.5 Million
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $293,190 - $323,179	-1,337 Reduced 16.79%	6,625 $1.55 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $866,189 - $1.35 Million	-3,997 Reduced 33.42%	7,962 $1.88 Million
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $86,613 - $109,705	311 Added 2.67%	11,959 $3.6 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $230,698 - $301,690	-786 Reduced 6.32%	11,648 $4.12 Million
Q2 2018 Aug 10, 2018	BUY	$257.52 - $306.91 $35,795 - $42,660	139 Added 1.13%	12,434 $3.61 Million
Q1 2018 Jun 28, 2018	BUY	$260.13 - $367.91 $1.83 Million - $2.59 Million	7,050 Added 134.41%	12,295 $3.37 Million
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $705,212 - $997,404	-2,711 Reduced 34.07%	5,245 $1.44 Million
Q4 2017 Feb 12, 2018	BUY	$307.64 - $344.58 $46,761 - $52,376	152 Added 1.95%	7,956 $2.53 Million
Q3 2017 Nov 13, 2017	SELL	$281.15 - $329.69 $1.39 Million - $1.63 Million	-4,942 Reduced 38.77%	7,804 $2.44 Million
Q2 2017 Aug 14, 2017	BUY	N/A	12,746	12,746 $3.46 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.

Account

Brown Advisory Inc Biogen Inc. Transaction History